Guardant Share Price
NASDAQ: GH | Large Cap | HealthcareGuardant Stock Performance
Guardant Share Price Today
As of 20 November 2026, Guardant Health, Inc.'s share price is $145.71. The stock opened at $148.50, compared to its previous close of $145.21. During today's trading session, Guardant Health, Inc.'s share price traded between $145.56 and $155.96, with an average price of $150.76. Over the past 52 weeks, the stock has recorded a high of $190.69 and a low of $74.71. In terms of performance, Guardant Health, Inc.'s share price has risen by 12.31% over the last six months and is up 34.43% on a year-on-year basis.
Guardant Share Price Chart
Guardant Quarterly Profit & Loss
All figures in USD
Guardant Annual Profit & Loss
All figures in USD
Guardant Balance Sheet
All figures in USD Million
Guardant Cash Flow
All figures in USD Million
About Guardant
Guardant Health, based in Redwood City, California, is a leader in liquid-based cancer tests for clinical and research use. The company's main franchises are Guardant360 for genomic profiling of tumors, Reveal for molecular residual disease testing, and Shield for colorectal cancer screening. Additionally, Guardant offers research development services such as regulatory approval consultancy and clinical trial referrals.
Guardant Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Nov 2026 | $179.00 | $145.66 | -18.38% |
Oct 2026 | $177.75 | $178.46 | -0.06% |
Sep 2026 | $157.99 | $178.56 | +6.02% |
Aug 2026 | $158.46 | $168.41 | +4.04% |
Jul 2026 | $159.69 | $161.87 | +7.81% |
Jun 2026 | $127.59 | $150.14 | +15.72% |
May 2026 | $87.91 | $129.74 | +48.82% |
Apr 2026 | $94.81 | $87.18 | -5.65% |
Mar 2026 | $92.89 | $92.41 | -1.65% |
Feb 2026 | $113.23 | $93.96 | -17.65% |
Jan 2026 | $101.98 | $114.10 | +11.74% |
Dec 2025 | $106.41 | $102.11 | -5.79% |